Molecular factors in intervertebral disc degeneration


https://doi.org/10.4081/jaarm.2017.7203
Vol. 1 No. 1 (2017)
Submitted: 27 April 2017
Accepted: 6 June 2017
Published: 15 June 2017
intervertebral disc degeneration, protein, mRNA, proteomics, human studies, literature review
Abstract Views: 1204
PDF: 454
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Jessie Zhang Mayo Clinic Neuro-Informatics Laboratory, Mayo Clinic, Rochester, MN, USA; Sydney Medical School, Universityof Sydney, Australia.
  • Victor M. Lu Mayo Clinic Neuro-Informatics Laboratory, Mayo Clinic, Rochester, MN, USA; Sydney Medical School, Universityof Sydney, Australia.
  • Andre J. van Wijnen Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, United States.
  • Panagiotis Kerezoudis Mayo Clinic Neuro-Informatics Laboratory, and Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, United States.
  • Isobel Yeap Mayo Clinic Neuro-Informatics Laboratory, Mayo Clinic, Rochester, MN, USA; Sydney Medical School, Universityof Sydney, Australia.
  • Lin Cong Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, United States.
  • Noelle Larson Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, United States.
  • Wenchun Qu Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, United States.
  • Ahmad Nassr Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, United States.
  • Mohamad Bydon
    bydon.mohamad@mayo.edu
    Mayo Clinic Neuro-Informatics Laboratory, and Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, United States.
The aim of this paper is to review the literature on molecular protein and messenger ribonucleic acid (mRNA) factors involved in intervertebral disc degeneration (IVDD). These elements were categorized basing on the changes in i) cell viability or number, ii) extracellular matrix (ECM) and iii) inflammation. Factors found to influence cell number and viability in IVDD included Fas/FasL, tumor necrosis factor related apoptosis-inducing ligand, death receptor-4/-5, bcl2-like 11, p53 inducible nuclear protein 1, p53/p21 factors, basic fibroblast growth factor and transforming growth factor-β. Factors found to affect IVD ECM included a range of matrix metalloproteinase, metalloproteinases with thrombospondin motifs, tissue inhibitors of metalloproteinases and disintegrins. Several proinflammatory factors have been identified in IVDD including interleukin-1β and TNF-α. The advent of protein and mRNA detection techniques has increased the understanding of IVDD from a molecular perspective. Further study of molecular protein and mRNA factors has the potential to identify and optimize therapeutic targets in the future.

Supporting Agencies


Zhang, J., Lu, V. M., van Wijnen, A. J., Kerezoudis, P., Yeap, I., Cong, L., Larson, N., Qu, W., Nassr, A., & Bydon, M. (2017). Molecular factors in intervertebral disc degeneration. Journal of the American Academy of Regenerative Medicine, 1(1). https://doi.org/10.4081/jaarm.2017.7203

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC